business
CVS Health (CVS) Price Target Boosted by $8 at Mizuho
Key takeaways
- America’s leading health solutions company, CVS Health Corporation (NYSE:CVS) provides advanced health care from pharmacy services and health plans to health and wellness.
- On May 20, Mizuho bumped up its price target on CVS Health Corporation (NYSE:CVS) from $102 to $110, while maintaining an ‘Outperform’ rating on the shares.
- Mizuho believes that the managed care group delivered strong results in the recent Q1 earnings season.
CVS Health (CVS) Price Target Boosted by $8 at Mizuho Sultan Khalid Mon, May 25, 2026 at 12:22 AM GMT+7 2 min read CVS With an annual dividend yield of 2.84%, CVS Health Corporation (NYSE:CVS) is included among the 12 Best Dividend Stocks to Invest in According to Hedge Funds.
America’s leading health solutions company, CVS Health Corporation (NYSE:CVS) provides advanced health care from pharmacy services and health plans to health and wellness.
On May 20, Mizuho bumped up its price target on CVS Health Corporation (NYSE:CVS) from $102 to $110, while maintaining an ‘Outperform’ rating on the shares. The target boost represents an upside of over 17% from the current share price.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop